Stryker announced yesterday a definitive agreement to acquire Vertos Medical. The privately held Vertos offers a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
Millions of people suffer from lumbar spinal stenosis, a leading cause of pain and disability. According to the National Institutes of Health, lumbar spinal stenosis affects some 11% of older adults in the U.S., and about 103 million people worldwide.
Vertos Medical's mild® procedure provides a solution for pain relief and may improve mobility1 without major surgery. The prospect of minimally invasive treatment offers patients reduced recovery times.
Most Read Medical News:
- FDA Approves 'Mask-Free' Sleep Apnea Treatment Device
- Johnson & Johnson to Acquire V-Wave for $1.1 Billion
- Total Artificial Heart Implanted in First Human Patient
- Mayo Clinic Offers New Therapy to Treat Atrial Fibrillation
In a statement, Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, said the acquisition strengthens the company's minimally invasive pain management portfolio with differentiated treatments and expands reach across ambulatory surgery centers.
The transaction is subject to customary closing conditions, financial details were not disclosed. Stryker and Vertos Medical will continue to operate as separate entities and proceed with business as usual until the transaction closes.
Click here to subscribe to our daily newsletter featuring breaking medical design engineering industry news.
References:
- Deer TR, Chafin TB, Costandi SJ, Qu H, Kim C, Jassal N, Patel K, Calodney A. The MOTION study: Two-year results of a real-world randomized controlled trial of the mild® procedure for treatment of lumbar spinal stenosis. Pain Pract. 2024 Jan;24(1):109-119.Deer TR, Costandi SJ, Washabaugh E, Chafin TB, Wahezi SE, Jassal N, Sayed D. The MOTION Study: A Randomized Controlled Trial with Objective Real-World Outcomes for Lumbar Spinal Stenosis Patients Treated with the mild® Procedure: One-Year Results. Pain Med. 2022 Apr 8;23(4):625-634.
